Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody

Journal of Immunology

Volumn 167, Issue 2, 2001, Pages 699-707

  Chung, D H ^a   Belyakov, I M ^a   Derby, M A ^a   Wang, J ^a   Boyd, L F ^a   Berzofsky, J A ^a   Margulies, D H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOFLUORESCENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS STRAIN;

EID: 0035879353     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.2.699     Document Type: Article

References (63)

1. Organ-specific autoimmunity
2. Systemic autoimmunity
3. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
4. Molecular mimicry and autoimmunity
5. Molecular mimicry and multiple sclerosis: Degenerate T-cell recognition and the induction of autoimmunity
6. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts
7. Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody production
8. Induction of tolerance by monoclonal antibody therapy
9. Induction of immune tolerance by administration of monoclonal antibody to L3T4
10. Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks αβ T cell-mediated rejection of intestinal allografts in mice
11. Tolerance induction in the adult using monoclonal antibodies to CD4, CD8, and CD11a (LFA-1)
12. Anti-CD8 treatment reduces the severity of inflammatory arthritis, but not vasculitis, in mercuric chloride-induced autoimmunity
13. Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies
14. Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies
15. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation
16. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: A comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade
17. Maternal immunization with a soluble TCR-Ig chimeric protein: Long term, Vβ-8 family-specific suppression of T cells by maternally transferred antibodies
18. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis
19. In vivo treatment with a MHC class 1-restricted blocking peptide can prevent virus-induced autoimmune diabetes
20. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: Enhanced in vivo potency of encephalitogenic peptides
21. A conformationally-constrained MHC class II 1-Ag7-derived peptide protects NOD mice from the development of diabetes
22. MHC-based diagnostics and therapeutics: Clinical applications for disease-linked genes
23. Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex
24. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody
25. Modulation of the immune response in multiple sclerosis: Production of monoclonal antibodies specific to HLA/myelin basic protein
26. A study of complexes of class II invariant chain peptide: Major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody
27. Monoclonal antibodies directed against T cell epitopes presented by class I MHC antigens
28. Recombinant antibodies with the antigen-specific, MHC restricted specificity of T cells: Novel reagents for basic and clinical investigations and immunotherapy
29. A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells
30. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody
31. Antibodies directed against the MHC-I molecule H-2D(d) complexed with an antigenic peptide: Similarities to a T cell receptor with the same specificity
32. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: A 13 residue consensus peptide specifies biotinylation in Escherichia coli
33. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules
34. Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules
35. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule
36. d exploits a four residue peptide binding motif
37. d complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120
38. Phenotypic analysis of antigen-specific T lymphocytes
39. 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules
40. 2-microglobulin regulation of cell surface MHC class I conformation and expression
41. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus
42. A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160
43. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes
44. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge
45. d interact with NK and TCR
46. A three-domain T cell receptor is biologically active and specifically stains cell surface MHC/peptide complexes
47. Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance: Peptide immobilization and characterization of binding specificity
48. Measuring interactions of MHC class I molecules using surface plasmon resonance
49. Exon shuffling: Mapping polymorphic determinants on hybrid mouse transplantation antigens
50. Serologic and T cell recognition of truncated transplantation antigens encoded by in vitro deleted class I major histocompatibility genes
51. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy
52. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL
53. Preferential Vβ usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction
54. A T cell receptor-specific blockade of positive selection
55. Prophylaxis and treatment of acute graft-versus-host disease: Current state, implications of new immunopharmacologic compounds and future strategies to prevent and treat acute GVHD in high-risk patients
56. + cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12
57. Cell mediated immunity in virus infections
58. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell- deficient mice
59. + lymphocytes using a mouse-human chimeric monoclonal antibody
60. + T cell depletion in simian immunodeficiency virus-infected macaques
61. + lymphocytes
62. Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections
63. Two intermediate avidity CTL clones with a disparity between functional avidity and MHC tetramer staining